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Abstract
Ischemia is a primary cause of neuronal death in retinal diseases. The repertoire of 
expressed transmitter receptors would determine the neurons’ responses to ischemic 
damage, and peptidergic receptors may be involved. With a new in vitro model of the 
ischemic mouse retina, we investigated whether an altered expression of somatostatin 
receptors could modulate retinal responses to ischemia. We used retinas of somatostatin 
receptor 1 (sst1) knock out (KO) mice, where sst2 are over-expressed and over-
functional, and of sst2 KO mice. TUNEL analysis of ischemic retinas showed a marked 
reduction of cell death in sst1 KO retinas, while there were no differences between wild 
type (WT) and sst2 KO retinas. In addition, caspase-3 mRNA expression was also 
reduced in sst1 KO as compared to WT retinas. An immunohistochemical analysis 
demonstrated that different cell populations responded differently to the ischemic insult, 
and that the persistence of some immunohistochemical markers was greater in sst1 KO 
than in WT or in sst2 KO retinas. In particular, rod bipolar cell survival was markedly 
improved in sst1 KO retinas, while it was dramatically decreased in sst2 KO retinas. 
Furthermore, consistent with a role of glutamate excitotoxicity in ischemia-induced 
neuronal death, retinal glutamate release was observed to increase under ischemic 
conditions, but this increase was significantly reduced in sst1 KO retinas. These 
observations demonstrate that an increased presence of functional sst2 protects against 
retinal ischemia, thus implementing the background for the use of sst2 analogs in 
therapies of retinal diseases such as glaucoma or diabetic retinopathy.
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Introduction
The primary cause of neuronal death in the diseased retina is ischemia, a condition that 
can be considered a final common pathway for injury in different retinal pathologies 
(Osborne et al., 2004). Both excessive glutamate release and apoptotic mechanisms are 
involved in the process of ischemia-induced neuronal cell death (Won et al., 2002).
A number of in vitro models of the ischemic retina have been developed (Neal et 
al., 1994; Osborne et al., 1997; Maynard et al., 1998; Quinones-Hinojosa et al., 1999; 
Tezel & Wax, 1999; Kuriyama et al., 2001; Luo et al., 2001; Napper et al., 2001; Endo
et al., 2002; Tamada et al., 2002; Izumi et al., 2003; Bull & Barnett, 2004; Payet et al., 
2004; Ueda et al., 2004; Kinukawa et al., 2005; Mastrodimou et al., 2005). In these 
models, different levels of oxygen supply and of glucose availability have been 
employed. In addition, different animal species ranging from chicks to rats, rabbits or 
pigs have been used. Notably, no in vitro experimental models of the ischemic mouse 
retina have been reported, to our knowledge, up to now. The first aim of the present 
work was to establish an in vitro model of the ischemic mouse retina, providing the 
evidence of the presence of apoptotic markers, the characterization of cell death in each 
retinal layer and in selected, immunohistochemically-identified neuronal populations, 
and the correlation of the ischemic damage with the rate of glutamate release.
Using this model and mice with genetic alterations of the somatostatinergic system, 
we then aimed at investigating possible actions of the peptide somatostatin 
(somatotropin release-inhibiting factor, SRIF) in the rescue of retinal cells from 
ischemic damage. SRIF and its receptor subtypes (sst1 through sst5) are expressed in the 
retina (Bagnoli et al., 2003; Thermos, 2003; Casini et al., 2005), where SRIF may 
influence cell functions and transmitter release (Vasilaki et al., 2002; Mastrodimou & 
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Thermos, 2004; Pavan et al., 2004; Casini et al., 2005; Kouvidi et al., 2006), including 
glutamate release (Dal Monte et al., 2003a). Interestingly, activation of sst2 receptors by 
SRIF or its analogs protects retinal neurons against ischemia-induced damage (Celiker 
& Ilhan, 2002; Mastrodimou et al., 2005). Transgenic mice with sst1 or sst2 receptor 
deletion have been generated (Zheng et al., 1997; Kreienkamp et al., 1999; Allen et al., 
2003). In their retinas, sst1 and sst2 receptor expressions have been found to compensate 
for each other. Indeed, sst1 receptor loss causes an increased expression of sst2
receptors, while genetic deletion of the sst2 receptor induces an increased expression of 
the sst1 receptor (Dal Monte et al., 2003b; Casini et al., 2004; Casini et al., 2005). In 
addition, recent findings indicate that sst2 receptor over-expression is correlated with 
enhanced sst2 receptor function (Bigiani et al., 2004; Pavan et al., 2004). The second 
aim of the present study was to assess the consequences of ischemic treatment in sst1
KO and in sst2 KO retinas, with the hypothesis that, compared to WT retinas, a chronic 
over-expression of sst2 receptors (as in sst1 KO retinas) may reduce the ischemic 




Experiments were performed on mouse retinas of WT (C57BL/6) and sst1 or sst2 KO 
strains (Kreienkamp et al., 1999; Allen et al., 2003) of both sexes. Experiments were 
performed in compliance with the Italian law on animal care N° 116/1992 and in 
accordance with the European Community Council Directive (EEC/609/86). In all 
experiments, mice were anesthetized by i.p. injection of Avertin (1.2% tribromoethanol 
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and 2.4% amylene hydrate in distilled water, 0.02 ml/gm body weight; Sigma) and 
killed by cervical dislocation. The retinas were rapidly dissected in phosphate-buffered 
saline (PBS) and subjected to ischemic treatment or incubated in control conditions. 
They were then used for the terminal-deoxynucleotidyl-transferase-mediated 
deoxyuridine triphosphate nick end labeling (TUNEL) assays, for the assessment of 
caspase-3 mRNA expression with semi-quantitative reverse transcription–polymerase 
chain reaction (RT-PCR), or for immunohistochemical labeling of selected retinal cell 
populations. Some of the incubation media were used for the determination of 
glutamate release with high performance liquid chromatography electrospray mass 
spectrometry  (HPLC ESI-MS). All experiments were performed at the same time of the 
day (between 9.00 and 11.00 a.m.) in order to exclude possible circadian influences. 
The data were collected from both male and female WT and KO mice; the results were 
combined since there was no apparent gender difference.
Ischemic treatment
The dissected retinas were incubated for different periods of time at 37°C in N2-
saturated PBS containing different concentrations of iodoacetic acid (IAA; Sigma) in 
airtight vials (ischemic treatment) or in air-saturated PBS containing 6mM glucose in 
open vials (control conditions). Experiments were conducted in order to set the 
conditions of the ischemic treatment to obtain a minimum and a maximum effect. We 
defined the "minimum effect" as that of having at least 20% cell death, determined with 
an analysis of the TUNEL staining (see below), in all three nuclear layers, i.e. the outer 
nuclear layer (ONL), the inner nuclear layer (INL) and the ganglion cell layer (GCL). 
The "maximum effect" was defined as that determining more than 90% cell death in at 
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least one of the nuclear layers. The minimum and the maximum effects were obtained 
using the same concentration of 250 mM IAA but with different incubation times: the 
minimum effect was observed after 1h incubation, while the maximum effect was 
observed after 6h. Data were also collected at 3h. Control retinas were incubated for 
corresponding periods in control conditions. In the cases of 3 or 6h incubation, both the 
ischemic and the control solutions were changed every hour.
Preparation of retinal sections
At the end of the incubation period, the retinas used for the TUNEL or the 
immunohistochemical stainings were immersion fixed in 4% paraformaldehyde in 0.1 
M phosphate buffer (PB) for 45’ – 60’ at room temperature and stored overnight in 25% 
sucrose in 0.1 M PB at 4°C. Retinal sections were cut perpendicularly to the vitreal 
surface at 10 µm with a cryostat, mounted onto gelatin-coated slides and stored at -
20°C. All retinas were cut with the same temporal-to-nasal orientation. Consecutive 
sections were alternately put onto a series of five slides, so that on each slide the 
sections were spaced every 50 µm. Five sections were put on each slide, and five series 
of slides were prepared from each retina. Corresponding series of ischemic and control 
sections were used in each experiment. Three retinas were analyzed for each 
experimental condition. At least two series of slides from each retina were used for the 
TUNEL staining, while the remaining slides were used for immunohistochemistry.
TUNEL staining and quantitative analysis
An in situ cell death detection kit (Roche Diagnostics) was used to identify apoptotic 
profiles by TUNEL technique according to the manufacturer’s instructions. The slides 
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were coverslipped in a 0.1 M PB-glycerin mixture containing 0.5 µg/ml of 4'-6-
diamidino-2-phenylindole (DAPI, Sigma).
The fluorescent TUNEL staining was evaluated in selected sections to calculate an 
index of cell death in the nuclear layers of the retina. The measurements were obtained 
with a system of computer-assisted image analysis using Zeiss Axiovision 4 and KS-
300 software. Images of both the TUNEL and the DAPI stainings were acquired with a 
digital photocamera (Axiocam MRC) connected to a Zeiss microscope equipped with 
epi-fluorescence. The digital images were optimized for contrast and brightness using 
Adobe Photoshop (Adobe Systems, Mountain View, CA, USA). For the quantitative 
analysis, a field about 90 µm wide was selected in each image (see figure 1). In the 
GCL, the index of cell death was calculated as the ratio between the number of the 
TUNEL-labeled and that of the DAPI-stained cells. In contrast, it was very difficult to 
count individual TUNEL-positive cells in the ONL and in the INL, and the index of cell 
death in these layers was calculated as follows: both the DAPI and the TUNEL images 
relative to the same field were visualized. Using the KS-300 software, the areas of the 
ONL and of the INL in the DAPI image were measured. Subsequently, the TUNEL 
image was thresholded and the labeled areas in the ONL and in the INL were measured. 
The ratio between the area covered by the TUNEL staining and the area of the retinal 
layer seen with the DAPI counterstain was taken as an index of cell death. In the 
remainder of the paper and in the figures, the expressions  “percentage of cell death” or 
“% of cell death” refer equally to the indexes calculated in the GCL and to those 
calculated in the ONL or INL.
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Caspase-3 semi-quantitative RT-PCR
The expression of caspase-3 mRNA was evaluated by semi-quantitative RT-PCR in WT 
and in sst1 KO retinas. Total cellular RNA was extracted with the Micro-to-Midi Total 
RNA Purification System (Invitrogen, Milano, Italy), according to the manufacturer’s 
recommended procedure. cDNA was synthesized from 1 µg total RNA using a first 
strand cDNA synthesis kit (F. Hoffmann-La Roche, Basel, Switzerland). Primer pairs 
for caspase-3 (Eurobio, Les Ulis, France) were designed to hybridize to unique regions 
of the respective mouse sequence; forward: AGCAGCTTTGTGTGTGTGATTCTAA; 
reverse: GTCTGACTGGAAAGCCGAAACT). Cyclophilin B mRNA, whose 
expression is unchanged in ischemic retinas (Agardh et al., 2006), was used as an 
internal standard (Cristiani et al., 2002). The PCR reactions were carried out using 1 µg 
of cDNA in a 25 µl total volume of PCR buffer (Promega), containing 1.5 mM MgCl2, 
2.5 mM dNTP, and 0.75 µM of appropriate primers and Taq polymerase (1.2 U, 
Promega). The amplification reaction was carried out in a Bio-Rad thermocycler for 35 
cycles. A 25 µl sample of the PCR reaction was electrophoresed on a 3% agarose gel 
using the Bio-Rad Sub-cell GT system and stained with BMA GelStar (Rockland, ME, 
USA). After migration, bands corresponding to the amplified products were analyzed 
with Gel Doc 2000 System equipped with Quantity One software (Bio-Rad). Semi-
quantitative analysis of the caspase-3 PCR products was performed by measuring the 
optical density of the bands corresponding to caspase-3 mRNA normalized to the 
optical density of the band corresponding to the respective cyclophilin B mRNA.
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Immunohistochemistry
The set of primary antibodies used in these studies was designed to label neuronal 
populations among photoreceptors, bipolar cells, amacrine cells and ganglion cells. In 
particular, antibodies to cone arrestin (1:500) were employed to label cone 
photoreceptors; calbindin (1:2000) for horizontal cells; the calcium binding protein 
CaBP5 (1:500) and the MAb115A10 antibody (1:3000) for multiple types of bipolar 
cells; the G protein G13 (1:1000) for populations of ON-bipolar cells; protein kinase C 
(PKC, 1:200) for rod bipolar cells; GABA transporter-1 (GAT-1, 1:200), choline 
acetyltransferase (ChAT, 1:50), tyrosine hydroxylase (TH, 1:400) and SRIF (1:100) for 
different populations of amacrine cells; -Tubulin (1:400) for ganglion cells. In 
addition, antibodies to the sst2A receptor  were also employed. The slides were air dried 
before immunohistochemical procedures. Then, the sections were washed in 0.1 M PB 
and incubated overnight at 4 °C in each one of the primary antibodies diluted in 0.1 M 
PB containing 0.5% Triton X-100. Following washes in 0.1 M PB, the sections were 
incubated with the appropriate secondary antibody conjugated with Alexa Fluor 488 
(Molecular Probes) at a dilution of 1:200 in 0.1 M PB containing 0.5% Triton X-100 for 
1h at room temperature. Finally, the slides were coverslipped in a 0.1 M PB–glycerin 
mixture containing 0.5 µg/ml DAPI.
An estimation of the differences in immunostaining patterns among the different 
experimental groups was coded in tables 2-4 with a scale of “+” and “-”, with “+++” 
indicating a picture similar to that of controls, “++” indicating a slight but evident 
reduction of immunofluorescence intensity and/or of immunostained cell parts 
(processes or somata), “+” indicating a dramatic decrease of immunostaining intensity 
and of immunostained structures, “+/-” indicating the occurrence of only limited 
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amounts of immunofluorescent material, “-” indicating the absence of any detectable 
immunofluorescence.
HPLC ESI-MS
The rate of glutamate release was measured using HPLC ESI-MS in WT and in sst1 KO 
retinas. At the end of the incubation period, the vials containing the ischemic and the 
control solutions were stored at -80°C. Glutamate levels were determined according to 
Li et al. (2005), with some modifications. Briefly, the samples were lyophilized and 
reconstituted in 100 µl of 10% acetonitrile (Carlo Erba, Milan, Italy). For chemical 
derivatization, they were incubated for 30 min in darkness at 60°C in a water bath with 
20 µl of 10M KOH and 500 µl of 10-4 M dansyl chloride (Sigma). HPLC was 
performed using a Beckman Model 126 Programming Solvent Module pump 
chromatograph (Beckman Instruments, Brea, CA). The chromatographic separations 
were carried out with Waters ODS2 Spherisorb 250 mm x 4.6 mm I.D. 5µm packed 
column (Teknokroma, Barcelona, Spain) as stationary phase, preceded by a guard 
column of Spherisorb RPC18, 5 µm, 4mm x 4mm. The mobile phase was DD water 
0.5% (v\v) formic acid (mobile phase A), and acetonitrile 0.5% (v\v) formic acid 
(mobile phase B). ESI–MS was performed on an ion trap mass spectrometer (Esquire 
3000 plus, Bruker Daltonik, Bremen, Germany) in the positive mode. For the  analysis 
with pneumatically assisted ESI, an electrospray voltage of 4 kV and a Nebulizer 35 psi 
and Dry Gas 10 L/min were employed. The temperature of dry gas was set to 300 °C. 
Full-scan spectra were acquired over the range m/z 50–1500 (scan duration, 1 sec.). 
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Statistics
In the TUNEL, RT-PCR and HPLC studies, the comparisons of the data were 
performed using ANOVA and Tukey’s multiple comparison post test upon verification 
of normal distribution. When specified, statistical significance was also evaluated using 
paired Student’s t-test. The software GraphPad Prism (Graph Software, San Diego, CA, 
USA) was used. p<0.05 was considered statistically significant. In all cases, the results 
are expressed as means ± S.E.M..
Figure preparation
Both the TUNEL and the immunofluorescence images were acquired using a 40x plan-
NEOFLUAR Zeiss objective, the Axiocam photocamera and the Zeiss Axiovision 4 
software. The digital images were sized and optimized for contrast and brightness using 
Adobe Photoshop. Final images were saved at a minimum of 300 dpi.
Results
TUNEL staining
In WT retinas incubated in control conditions, TUNEL labeling was not detected after 
1h, 3h or 6h incubation (Fig. 1F, left). The presence of apoptotic signs, instead, was 
evident in retinas incubated in the ischemic solution. Pyknotic nuclei, interpreted as 
apoptotic cells, could be detected in the DAPI images after 1h ischemic treatment (Fig. 
1A, left). This picture corresponded to the presence of a certain TUNEL labeling in the 
ONL, INL and GCL (Fig. 1A, center). In particular, in the thresholded TUNEL images 
(Fig. 1A, right), the ONL was apparently the retinal layer with the highest amount of 
staining, while a more scattered labeling could be seen in the INL. In the GCL, sparse 
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somata displayed TUNEL positivity. After 3h of ischemic treatment (Fig. 1B), more 
pyknotic  nuclei were seen with the DAPI staining, and a larger spread of TUNEL 
labeling was observed in the ONL and in the INL. In the GCL, virtually all cell bodies 
were TUNEL-positive. In the 6h treated retinas (Fig. 1C), both the number of pyknotic, 
DAPI-stained nuclei and the amount of the TUNEL labeling had further increased in the 
ONL and in the INL.
The quantitative analysis of the TUNEL-labeled retinal sections confirmed that the 
1h ischemic treatment resulted in the "minimum effect", with at least 20% cell death in 
each nuclear layer (see methods). In particular, cell death in the ONL was around 35%, 
in the INL slightly above 20% and in the GCL around 30% (Fig. 2A). The percentage of 
cell death significantly increased in all nuclear layers after 3h ischemic treatment, with 
values in the GCL approaching 90%. The 90% value was exceeded ("maximum effect") 
both in the ONL and in the GCL after 6h ischemia. Although the percentage of cell 
death appeared to be increased in all nuclear layers, a statistically significant increment 
with respect to the 3h treatment was only observed in the ONL.
The percentages of cell death were also compared in WT, sst1 KO and sst2 KO 
ischemic retinas. Similar to WT retinas, TUNEL staining was not detected in sst1 KO or 
in sst2 KO retinas incubated in control conditions for 1h, 3h or 6h (Fig. 1F, center and 
right). Figure 1D and 1E shows the DAPI staining, the TUNEL labeling and the 
thresholded TUNEL image in sst1 KO and in sst2 KO retinas, respectively, incubated for 
1h in ischemic conditions. It is apparent that the TUNEL labeling was more restricted in 
the sst1 KO retinas than in the WT or in the sst2 KO retinas. The quantitative analysis 
(Fig. 2B) confirmed that, after 1h ischemia, the percentage of cell death in the ONL, 
INL and GCL was significantly lower in sst1 KO retinas than in the corresponding 
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layers of WT or sst2 KO retinas. In particular, comparing WT with sst1 KO retinas, cell 
death in the ONL diminished from 35% to 17%, in the INL from 21% to 5%, and in the 
GCL from 28% to 9%. No differences were recorded between WT and sst2 KO retinas. 
After 3h ischemia, significant differences between sst1 KO and WT or sst2 KO retinas 
were no longer detected, and the percentages of cell death in sst1 KO retinas became 
similar to those in WT retinas (inset of figure 2B).
Caspase-3 expression
As shown in figure 3A, RT-PCR yielded amplification at 136 bp, which was the 
expected molecular weight of caspase-3 mRNA products. In samples from WT retinas 
incubated for 1h, 3h or 6h in control conditions, similar levels of caspase-3 mRNA 
expression were observed. In contrast, expression levels were significantly increased in 
1h ischemic retinas (around 30% higher compared to controls), while they were 
significantly reduced after 3h of ischemic treatment and absent after 6h (Fig. 3A-B). 
According to other studies of ischemic retinas (Agardh et al., 2006), the levels of 
cyclophilin-B mRNA, used as an internal standard, were similar both in controls and in 
ischemic retinas.
To assess whether the apparent, although partial, protection from cell death in sst1
KO retinas, as evaluated with the TUNEL staining, was accompanied by any changes in 
other apoptotic markers, caspase-3 expression was investigated with semi-quantitative 
RT-PCR in WT and in sst1 KO retinas after 1h ischemia. Both in WT and in sst1 KO 
retinas, amplification products were detected at 136 bp (caspase-3, Fig. 3C). Semi-
quantitative evaluations of the amplified products showed a highly significant reduction 
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(around 65%) of caspase-3 mRNA expression in sst1 KO retinas compared to WT 
retinas (Fig. 3D).
Immunohistochemistry
The immunohistochemical labelings of WT retinas incubated in control conditions did 
not differ from those of normal, untreated retinas. In contrast, there was a high degree of 
heterogeneity in the responses of the different cell populations to the ischemic insult. 
Indeed, the different immunohistochemical markers could be grouped into four classes 
according to their persistence in the WT ischemic retinas: i) markers whose expression 
patterns persisted unaltered in ischemic retinas up to 6h; ii) markers which displayed 
changes in response to ischemia at 1h, 3h and 6h; iii) markers which were severely 
reduced and disappeared after 3h or 6h ischemia; iv) markers which could not be 
detected in ischemic retinas after 1h treatment.
Class (i) included cone arrestin and GAT-1. Cone photoreceptors were labeled by 
antibodies directed to cone arrestin in control retinas and in ischemic retinas up to 6h 
without apparent changes in the immunolabeling pattern, the label intensity or the
number of immunopositive cone photoreceptors (Fig. 4A). Similarly, the GAT-1 
immunostaining (Fig. 4B) was basically unchanged in control and in ischemic retinas. A 
possible decrease in the intensity of GAT-1 immunostaining in the inner plexiform layer 
(IPL) after 6h ischemia was not consistently observed in all the samples examined. 
Class (ii) included -Tubulin, TH and PKC. As shown in figure 4C, -Tubulin 
immunopositive ganglion cells and processes in the IPL could be observed in control as 
well as in ischemic retinas. The ischemic treatment did not influence the occurrence of 
immunolabeled somata in the GCL, but determined a consistent decrease of the density 
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of -Tubulin containing fibers in the IPL. The TH immunostaining (Fig. 4D) was 
characterized by sparsely distributed somata in the proximal INL and a rich bundle of 
varicose fibers in the distal IPL in control retinas. In addition, TH-immunopositive 
processes were also in the middle IPL and in the INL directed towards the outer 
plexiform layer (OPL, arrows in fig. 4D). After 1h or 3h ischemic treatment, brightly 
immunostained cell bodies were still present, however the processes in the distal IPL 
had lost their varicosities and the fibers in the middle IPL or in the INL/OPL were no 
longer observed. After 6h ischemic treatment, the TH-immunostained fiber bundle in 
the IPL was severely reduced, although immunoreactive somata could still be observed. 
PKC immunoreactivity identified the population of rod bipolar cells (Fig. 4E). After 1h 
ischemic treatment, the immunofluorescence intensity was reduced and a lower number 
of immunolabeled somata were visible, although there were no apparent variations in 
the density of PKC-immunoreactive rod bipolar cell axons or axon terminals in the IPL. 
A feature that was consistently observed in the 1h ischemic retinas was the swelling of 
the distal segment of rod bipolar cell axons (arrows in Fig. 4E). After 3h and 6h 
ischemic treatment, PKC immunostaining in rod bipolar cell dendrites, somata and 
axons was further decreased. The PKC-immunoreactive axonal terminals in the IPL 
remained visible, and they appeared to be larger than in control retinas.
Class (iii) included the G protein G13 and SRIF. Numerous ON-bipolar cells were 
visualized by G13 immunoreactivity (Fig. 4F). After 1h ischemia, the distal portion of 
these cells still displayed G13-immunostaining, while bipolar cell axons and terminals 
were faintly labeled. After 3h ischemia, only a band of immunostaining was left in the 
OPL, and after 6h ischemia G13 immunoreactivity could not be detected. SRIF-
containing amacrine cells (Fig. 4G) were very sparsely distributed, and varicose SRIF-
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immunostained processes were mainly seen in distal IPL of control retinas. After 1h 
ischemic treatment, SRIF-immunopositive somata were not detected, and only a few 
immunolabeled fibers could be observed in the IPL. Longer ischemic treatments 
completely abolished SRIF immunoreactivity.
Class (iv) included calbindin, MAb115A10, CaBP5 and ChAT. While these markers 
were easily observed in the appropriate cell types in retinas incubated in control 
conditions, none of them were detectable by immunohistochemistry in retinas subjected 
to 1h ischemic treatment (not shown).
After this immunohistochemical characterization of the effects of the ischemic 
treatment in WT retinas, we tested whether selected populations of retinal neurons were 
differentially affected by the ischemic treatment in sst1 KO and/or in sst2 KO retinas. 
The results are summarized in Tables 1 and 2. Appreciable and consistent differences 
were observed in the immunostaining patterns of TH and of three different bipolar cell 
markers, namely PKC, MAb115A10 and CaBP5. Such differences were not observed in 
the immunostaining patterns of the other markers listed in table 1. TH and PKC belong 
to the “class (ii)” markers, while MAb115A10 and CaBP5 belong to “class (iv)”.
Figure 5 shows that the TH immunostaining was preserved without notable changes 
at least up to 3h ischemic treatment in sst1 KO as well as in sst2 KO retinas (see also 
Tab. 1 and 2). Indeed, while in WT retinas there was a prominent decrease of varicose, 
TH-immunoreactive processes (Fig. 5A), a pattern of TH-containing fibers similar to 
the control was observed in sst1 KO (Fig. 5B) and in sst2 KO (Fig. 5C) retinas. A similar 
pattern was also maintained after 6h ischemia (Tab. 2).
With respect to PKC-immunolabeled rod bipolar cells of WT retinas (Fig. 6A), 
those of sst1 KO retinas appeared less susceptible to ischemic damage after both 1h and 
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3h ischemic treatment (Fig. 6B, Tab. 1 and 2). Indeed, after 1h ischemia rod bipolar 
cells of sst1 KO retinas did not display the swelling of their distal axons, which was 
instead a characteristic of rod bipolar cells in the 1h ischemic WT retina. In addition, 
both after 1h and 3h ischemia, the intensity of PKC immunostaining was considerably 
stronger in sst1 KO than in WT retinas. In sst2 KO retinas (Fig. 6C), the PKC 
immunoreactive pattern in control conditions was similar to that of WT and sst1 KO 
retinas in the same conditions. However, after 1h or 3h ischemia the PKC 
immunostaining in sst2 KO retinas was barely detectable and dramatically less intense 
than in WT and in sst1 KO retinas. After 6h ischemia, sst1 KO retinas still displayed 
stronger PKC immunoreactivity than WT retinas, while immunostaining was not 
detected in sst2 KO retinas (Tab. 2).
Similar to WT retinas, MAb115A10 immunoreactivity disappeared after 1h 
ischemia in sst2 KO retinas. In contrast, some weak immunostaining was still visible in 
the OPL of 1h ischemic sst1 KO retinas, where dendrites of MAb115A10-expressing 
bipolar cells could be detected (not shown). No immunolabeling was observed in 
bipolar cell somata, axons or axonal terminals in the IPL. After 3h or 6h ischemia, 
MAb115A10 immunoreactivity was completely absent in all the retinas analyzed.
Similar to MAb115A10, also CaBP5 immunoreactivity was absent in WT (Fig. 7A) 
and in sst2 KO (Fig. 7C) retinas after 1h or 3h ischemia. In 1h ischemic sst1 KO retinas 
(Fig. 7B and Tab. 1), instead, strong CaBP5 immunostaining could be observed in 
dendrites, somata, axons and axon terminals of numerous bipolar cells. After 3h 
ischemia, immunofluorescent bipolar cell dendrites, somata and axonal terminals were 
still visible in sst1 KO retinas (Fig. 7B and Tab. 2). After 6h ischemia, some 
immunolabeling could still be detected in sst1 KO retinas (Tab. 2).
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The immunostaining patterns of the sst2A receptor were investigated to ascertain 
whether sst2 receptors were still present in WT and/or sst1 KO retinas after ischemic 
treatment. In both WT and sst1 KO control retinas, these patterns were consistent with 
those described previously (Cristiani et al., 2002; Casini et al., 2004), with sst2A
immunoreactivity localized to, mainly, amacrine cells and rod bipolar cells. After 1h 
ischemia, while sst2A immunofluorescence was not affected in the amacrine cells, it was 
reduced in the rod bipolar cells (not shown). This reduction was less pronounced in sst1
KO than in WT retinas, consistent with the PKC immunostaining in ischemic retinas 
described above.
Glutamate release
In WT retinas incubated in control conditions, measured glutamate release was 
0.29±0.04 µg/ml after 1h, 0.39±0.03 µg/ml after 3h, and 0.43±0.02 µg/ml after 6h. 
There were no significant differences between these values, and they were in the range 
of previously reported measurements of glutamate release in the mouse retina (Dal 
Monte et al., 2003a). A three-fold increase of glutamate release was observed in 1h 
ischemic retinas, and further increases were detected after 3h and after 6h incubation in 
ischemic conditions (Fig. 8A).
To assess whether the apparent reduced susceptibility of sst1 KO retinas to the 
ischemic treatment was concomitant with differences in the rate of glutamate release, 
this release was evaluated in WT and in sst1 KO retinas after 1h or 3h incubation in 
control or in ischemic conditions. Comparable values were recorded in WT and in sst1
KO retinas incubated in control conditions both after 1h and after 3h. In contrast, as 
shown in figure 8B, there were differences in the ischemic retinas. Indeed, after 1h or 
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3h ischemic treatment, the rate of glutamate release in sst1 KO retinas was significantly 
reduced compared to that in WT retinas.
Discussion
In vitro ischemic model of the mouse retina
In the present work, we have established a reliable in vitro model of the ischemic mouse 
retina. This model, and its possible variants, may prove useful for investigations of the 
retinas of transgenic mice in relation to their responses to ischemic conditions, as we 
did in this study.
Apoptosis
The presence of TUNEL labeling in ischemic retinas and the increase of caspase-3 
mRNA expression after 1h ischemia suggest that retinal cells in our ischemic in vitro 
model die by apoptotic mechanisms. Indeed, in the retina, it has been shown that 
ischemia-induced apoptosis is executed at least in part by  caspase-3, which is likely to 
preferentially act in the INL and GCL, an that preventing caspase activation protects 
against ischemia-induced retinal damage (Katai & Yoshimura, 1999).
We have observed an increased caspase-3 mRNA expression after 1h ischemic 
treatment, followed by a decrease. This observation is consistent with observations in in 
vivo retinal models of ischemia-reperfusion or permanently increased intraocular 
pressure, reporting peaks of caspase-3 expression in the early phases of the apoptotic 
process (Yamamoto et al., 2006).
In in vitro models of retinal ischemia, both TUNEL labeling and the activation of 
caspase-3 have been reported in E1A.NR3 retinal cell line exposed to ischemic 
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treatment (Tezel & Wax, 1999), and TUNEL staining has also been evaluated in rat 
eyecup preparations treated for chemical ischemia (Mastrodimou et al., 2005). 
Mastrodimou and colleagues (Mastrodimou et al., 2005) reported elevated TUNEL 
staining and almost complete disappearance of ChAT immunostaining in rat retinas 
after 6h incubation in control conditions. In contrast, in mouse retinas, we have noticed 
absence of TUNEL staining and permanence of unaltered immunolabelings (including 
ChAT immunolabeling) up to 6h incubation in PBS. The reduced survival during 
incubation in control conditions of the rat retina compared to the mouse retina can be 
explained with intrinsic species differences and/or with different sample preparations 
(rat eyecups vs. mouse dissected retinas).
Immunohistochemical markers
Several different immunohistochemical markers of retinal cell populations have been 
investigated in the present study to characterize the in vitro ischemic mouse retina. In an 
in vitro model of the rat retina, ChAT, TH, PKC and brain nitric oxide synthase 
immunoreactivities disappear after incubation in ischemic conditions (Mastrodimou et 
al., 2005). Instead, in our model of the mouse retina, of these markers, only ChAT is 
absent in ischemic retinas, while TH and PKC immunolabelings persist, at least to a 
certain extent, in the presence of ischemic treatment. These discrepancies may be 
explained with the different composition of the ischemic solution, which, in the study of 
Mastrdimou and colleagues (2005), in addition to IAA also contained NaCN, a potent 
inhibitor of the respiratory chain.
We found that different immunohistochemical markers are differentially affected by 
ischemia in our model. Similar observations have been reported for markers of 
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amacrine cell populations in an ischemia-reperfusion model of the rat retina both at the 
level of mRNA expression and at the level of immunohistochemical localization (Dijk 
& Kamphuis, 2004; Dijk et al., 2004). In addition, retinal ischemia in the rat induced by 
bilateral common carotid artery occlusion differentially affects immunohistochemical 
markers for different retinal cell populations (Yamamoto et al., 2006).
The partial resistance to ischemic damage of some neuronal types may depend on 
the quantity and type of glutamate receptors that they express. It is interesting to note 
that, although dopaminergic amacrine cells are responsive to glutamate, the density of 
AMPA type glutamate receptors is lower in TH-containing neurons than in other 
amacrine or ganglion cells (Gabriel et al., 2002). In addition, although the majority of 
retinal neurons are activated by glutamate agonists at ionotropic receptors, ON-bipolar 
cells (which include the PKC-containing rod bipolar cells and the G13-expressing 
bipolar cells) are not responsive to these agonists, also in accordance to localization 
studies demonstrating scarce expression of ionotropic glutamate receptors in these cells 
(Sun & Kalloniatis, 2006).
Glutamate release
The data of glutamate release are in line with the hypothesis that one cause of cell death 
following an ischemic insult is excitotoxicity. Indeed, glutamate levels in the incubation 
medium have been found to increase in parallel with the intensity of the ischemic 
treatment. Interestingly, a correlation between caspase-3 and glutamate has been 
previously noted in dying neurons of the central nervous system. In particular, 
glutamate-induced apoptosis of cerebrocortical and cerebellar granule neurons appears 
to be mediated by activation of caspase-3 (Du et al., 1997; Tenneti & Lipton, 2000).
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Studies with sst1 KO and sst2 KO retinas
Preliminary considerations: are the experimental data fully consistent with the 
hypotheses?
Our hypothesis was that overexpression of sst2 receptors, as in sst1 KO retinas, would 
confer protection against ischemia and that, on the other hand, lack of sst2 receptors, as 
in sst2 KO retinas, would worsen the ischemic damage. The experimental data 
demonstrate that, indeed, sst1 KO retinas are to some extent protected from ischemia 
and that the loss of sst2 receptors after ischemic treatment is less severe in sst1 KO than 
in WT retinas. In contrast, the more serious effects that were expected in sst2 KO retinas 
were not detected, but the consequences of the ischemic treatment in these retinas were 
unexpectedly variegated. Indeed, although most cells in these retinas displayed ischemic 
damages similar to those in WT retinas, the dopaminergic amacrine cells appeared to be 
totally spared by ischemia, as in the sst1 KO retina. The opposite was instead observed 
in the population of rod bipolar cells, which in sst2 KO retinas resulted much more 
damaged by ischemia than in WT retinas.
The mechanism by which overexpression of sst2 receptors results in protection from 
the ischemic damage is likely to involve sst2-mediated reduction of glutamate release. 
Indeed, we observed a significant reduction of glutamate release in sst1 KO retinas 
compared to WT retinas after ischemic treatment. However, if on the one hand the 
reduced cell death in sst1 KO retinas, as evaluated with TUNEL analysis, is likely to be 
correlated with reduced glutamate release after 1h ischemia, on the other hand this 
correlation is no longer apparent after 3h ischemia, when glutamate release in sst1 KO 
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retinas is still significantly lower than in WT retinas but the percentage of cell death is 
similar.
In summary, our observations are consistent with the hypothesis that the protection 
from ischemic damage in sst1 KO retinas is due to enhanced sst2 receptor expression 
and function in these retinas (Dal Monte et al., 2003b; Bigiani et al., 2004; Pavan et al., 
2004; Casini et al., 2005). This conclusion is also supported by previous data reporting 
that ischemia-induced retinal damage can be prevented by administration of sst2
receptor-specific agonists (Celiker & Ilhan, 2002; Mastrodimou et al., 2005). However, 
the data obtained in our experimental model indicate that a higher level of complexity 
than the one evidenced by these previous studies must be present within the 
mechanisms linking sst2 receptor functional actions, glutamate release and apoptosis in 
the control of neuronal survival in the ischemic retina, and further studies will be 
necessary to elucidate these issues.
Mechanisms of protection from ischemia in sst1 KO retinas
Retinal cells in the sst1 KO retina may be protected from ischemia by virtue of two 
different mechanisms. The first one is ultimately concerned with the rate of glutamate 
release, whose increase in ischemia is likely to be responsible of neuronal deaths 
(Osborne et al., 2004). In ischemic conditions, glutamate release would be less 
enhanced in sst1 KO than in WT retinas, and the neuronal damage by excitotoxicity 
would be reduced. This hypothesis is strongly supported by the observation that 
glutamate release in sst1 KO ischemic retinas is significantly reduced with respect to 
WT ischemic retinas. In addition, SRIF acting at sst2 receptors has been reported to 
reduce glutamate release in the retina (Dal Monte et al., 2003a), and this action is 
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amplified in sst1 KO retinas (Bigiani et al., 2004). Although this mechanism is 
consistent with the survival of a significant quantity of neurons in all nuclear layers, as 
determined with the TUNEL analysis, it does not explain why large populations of cells 
such as horizontal cells and ganglion cells, that are activated by glutamate agonists at 
ionotropic receptors (Sun & Kalloniatis, 2006), are not spared in sst1 KO retinas. 
Instead, the main improvement in cell survival is seen, with immunohistochemistry, in 
rod bipolar cells, which do not respond to ionotropic glutamate receptor agonists (Sun 
& Kalloniatis, 2006), and in dopaminergic amacrine cells, which display relatively low 
concentration of glutamate receptors (Gabriel et al., 2002). The second mechanism is 
concerned with some positive action that may be exerted by SRIF directly on the cells 
expressing sst2 receptors. In sst1 KO retinas, this action would be stronger than in WT 
or in sst2 KO retinas, and it would explain why survival is improved in cell populations 
that express high levels of sst2 receptors, namely the rod bipolar cells and the 
dopaminergic amacrine cells (Cristiani et al., 2002). It would also explain the 
observation that the ischemic damage suffered by rod bipolar cells in sst2 KO retinas, 
where this “beneficial action” would be totally absent, is more severe than in WT 
retinas. However, this mechanism would not be totally consistent with the observed lack 
of enhanced survival in sst1 KO retinas of other populations of retinal cells expressing 
sst2 receptors, such as, for instance, the calbindin-containing horizontal cells (Cristiani
et al., 2002). We may propose that cell survival in sst1 KO ischemic retinas depends on 
both mechanisms, and it is promoted in those cells that over-express the sst2 receptors 
and that, at the same time, can sustain the excitotoxic stress which, although reduced by 
virtue of sst2-mediated inhibition of glutamate release, is likely to still affect the retina 
in ischemic conditions.
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Conclusions
We have set up a novel in vitro model of the ischemic mouse retina that may prove 
useful for investigations using transgenic animals. In this model, we have provided 
evidence that: i) an increased presence of functional sst2 receptors, as in sst1 KO retinas, 
protects against ischemic damage, thus confirming and expanding the notion that SRIF 
analogs acting at the sst2 receptor could represent valid therapeutic agents in 
degenerative retinal diseases such as glaucoma or diabetic retinopathy; ii) the 
mechanisms by which neuronal death is retarded in ischemic sst1 KO retinas likely 
includes both a sst2 receptor-mediated inhibition of excess glutamate release and a sst2-
mediated protective action directly in the neurons expressing these receptors; iii) the 
susceptibility of retinal neurons to ischemia depends not only on the type and the 
quantity of excitatory and inhibitory inputs mediated by glutamate and GABA 
receptors, but also on the type and the quantity of receptors responding to a wide range 
of neuroactive substances, including, for instance, neuropeptides.
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TABLE 1. Immunohistochemical markers after 1h ischemic treatment in WT, sst1 KO 
and sst2 KO retinas
Marker Control WT sst1 KO sst2 KO
Cone arrestin +++ +++ +++ +++
GAT-1 +++ +++ +++ +++
-Tubulin +++ ++ ++ ++
TH +++ ++ +++ * +++ *
PKC +++ ++ +++ * + #
G13 +++ +/- +/- +/-
SRIF +++ +/- +/- +/-
Calbindin +++ - - -
MAb115A10 +++ - +/- * -
CaBP5 +++ - ++ * -
ChAT +++ - - -
Markers in italic are those who displayed differences between WT and sst1 KO and/or 
sst2 KO retinas. * increase with respect to WT; # decrease with respect to WT.
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TABLE 2. Immunohistochemical markers after 3h or 6h ischemic treatment in WT, sst1
KO and sst2 KO retinas
Marker Control WT sst1 KO sst2 KO
TH (3h) +++ ++ +++ +++
PKC (3h) +++ + ++ +/-
CaBP5 (3h) +++ - + -
TH (6h) +++ + +++ +++
PKC (6h) +++ +/- + -
CaBP5 (6h) +++ - +/- -
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 Figure legends
Fig 1. Summary of TUNEL labeling in WT and in sst1 or sst2 KO ischemic retinas. 
Each panel shows the DAPI staining (on the left), the TUNEL labeling (in the 
center) and the thresholded TUNEL image (on the right). (A), (B) and (C) 
represent the WT ischemic retina after 1h, 3h or 6h incubation, respectively, in 
ischemic conditions. It is apparent that the amount of TUNEL labeling in the 
ONL, INL and GCL increases with increasing incubation times. Panel (D) shows 
a sst1 KO retina after 1h ischemia. In this case, the amount of TUNEL staining 
appears to be reduced in all nuclear layers as compared with the 1h ischemic WT 
retina (A). In contrast, the TUNEL labeling in the 1h ischemic sst2 KO retina (E) 
is similar to that in the WT (A). (F) shows sections, stained with both DAPI (left 
half of each photomicrograph) and TUNEL (right half), of WT, sst1 and sst2 KO 
retinas incubated for 3h in control conditions. Note the absence of TUNEL 
labeling. Similar pictures could be observed after 1h or 6h incubation in control 
conditions. Scale bar: 20 µm.
Fig 2. (A) Quantitative evaluation of TUNEL labeling in the ONL, INL and GCL after 
1, 3 or 6h ischemic treatment. *p<0.05, and **p<0.001 vs respective 1h values; § 
p<0.001 vs respective 3h values (ANOVA and Tukey’s post test). (B) Percentage 
of cell death in the ONL, INL and GCL after 1h ischemic treatment in WT, sst1
KO and sst2 KO retinas. * p<0.001 vs WT (ANOVA and Tukey’s post test). Inset: 
TUNEL labeling after 3h ischemic treatment in WT (light gray) and sst1 KO (dark 
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gray) retinas. The histograms represent means ± S.E.M. with N ranging from 20 to 
80.
Fig 3. (A) Caspase-3 mRNA in WT retinas after 1h, 3h and 6h ischemic treatment as 
evaluated by semi-quantitative RT-PCR using cyclophilin B mRNA as an internal 
standard. The control band (indicated with “C” in panel A) was from retinas 
incubated for 1h in control conditions and it was similar to those obtained after 3h 
or 6h (N=3, data not shown). As shown by the optical density (OD) measurements 
(B), the levels of caspase-3 mRNA in control retinas (filled bars) were similar at 
all the tested time periods. In contrast, they were significantly higher after 1h 
ischemia and significantly lower after 3h ischemia (gray bars; *p<0.001, ANOVA 
and Tukey’s post test, N=3 for each histogram). After 6h ischemia, caspase-3 
mRNA was not detected. (C) RT-PCR products corresponding to caspase-3 
mRNA after 1h ischemic treatment in WT and in sst1 KO retinas. (D) Caspase-3 
mRNA expression in 1h ischemic sst1 KO retinas was significantly lower than in 
1h ischemic WT retinas. MW, molecular weight. *p<0.0001, paired Student’s t-
test, N=5 for both WT and sst1 KO.
Fig 4. Summary of immunohistochemical markers of classes (i)-(iii) in WT control and 
ischemic retinas. Class (i): Arrestin-immunostained cone photoreceptors (A) and
GAT-1 immunolabeled amacrine cells (B). Class (ii):  tubulin immunostaining in 
ganglion cells (C); TH-containing amacrine cells (D) and PKC-expressing rod 
bipolar cells (E). The arrows in (D) indicate TH-immunopositive, varicose 
processes in the middle IPL and in the INL/OPL of control retinas. The arrows in 
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(E) point to swellings in the proximal part of the axons of rod bipolar cells after 1h 
ischemic treatment. Class (iii): G13-immunostaining in ON-type bipolar cells (F) 
and SRIF-containing amacrine cells (G). Scale bar: 20 µm.
Fig 5. TH immunolabeling in WT (A), sst1 KO (B) and in sst2 KO (C) retinas in control 
conditions and after 1h or 3h ischemic treatment. In contrast to WT retinas, the 
TH-containing fibers in both KO strains do not appear to be affected by the 
ischemic treatment. Scale bar: 20 µm.
Fig 6. PKC immunolabeling in WT (A), sst1 KO (B) and in sst2 KO (C) retinas in 
control conditions and after 1h or 3h ischemic treatment. Compared to WT retinas, 
rod bipolar cells appear to be less affected by ischemia in sst1 KO retinas, while 
they are more severely damaged in sst2 KO retinas. Scale bar: 20 µm.
Fig 7. CaBP5 immunolabeling in WT (A), sst1 KO (B) and in sst2 KO (C) retinas in 
control conditions and after 1h or 3h ischemic treatment. In contrast to WT and 
sst2 KO retinas, CaBP5-immunoreactive bipolar cells are present in sst1 KO 
retinas after 1h ischemic treatment. CaBP5 immunostaining can also be detected 
after 3h ischemia. Scale bar: 20 µm.
Fig 8. (A) Rate of glutamate release in WT control and in ischemic retinas after 1h, 3h 
or 6h incubation. Glutamate release increases with increasing duration of the 
ischemic treatment *p<0.001 vs respective control values; § p<0.001 vs respective 
1h value (ANOVA and Tukey’s multiple comparison test). N=3 in all cases, 
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except N=6 in the control at 1h incubation. (B) Rate of glutamate release in WT 
and in sst1 KO ischemic retinas after 1h or 3h incubation. Each histogram 
represent the percent value relative to the respective control value (dashed line). 
Glutamate release in the ischemic sst1 KO retina is significantly smaller than in 
ischemic WT retinas. *p<0.001 vs respective WT values (ANOVA and Tukey’s 
multiple comparison test). N=3 in all cases.
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